Cargando…

Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition

BACKGROUND: Glucocorticoid has a direct catabolic effect on skeletal muscle, leading to muscle atrophy, but no effective pharmacotherapy is available. We reported that clenbuterol (CB) induced masseter muscle hypertrophy and slow-to-fast myosin heavy chain (MHC) isoform transition through direct mus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umeki, Daisuke, Ohnuki, Yoshiki, Mototani, Yasumasa, Shiozawa, Kouichi, Suita, Kenji, Fujita, Takayuki, Nakamura, Yoshiki, Saeki, Yasutake, Okumura, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460071/ https://www.ncbi.nlm.nih.gov/pubmed/26053620 http://dx.doi.org/10.1371/journal.pone.0128263

Ejemplares similares

Role of phosphodiesterase 4 expression in the Epac1 signaling‐dependent skeletal muscle hypertrophic action of clenbuterol
por: Ohnuki, Yoshiki, et al.
Publicado: (2016)

Role of β-adrenergic signaling in masseter muscle
por: Ito, Aiko, et al.
Publicado: (2019)

Effects of occlusal disharmony on susceptibility to atrial fibrillation in mice
por: Suita, Kenji, et al.
Publicado: (2020)

Effects of occlusal disharmony on cardiac fibrosis, myocyte apoptosis and myocyte oxidative DNA damage in mice
por: Yagisawa, Yuka, et al.
Publicado: (2020)

Enhancement of Force Generated by Individual Myosin Heads in Skinned Rabbit Psoas Muscle Fibers at Low Ionic Strength
por: Sugi, Haruo, et al.
Publicado: (2013)

Definite Differences between In Vitro Actin-Myosin Sliding and Muscle Contraction as Revealed Using Antibodies to Myosin Head
por: Sugi, Haruo, et al.
Publicado: (2014)

Epac activation inhibits IL-6-induced cardiac myocyte dysfunction
por: Jin, Huiling, et al.
Publicado: (2016)

Correction to: Epac activation inhibits IL-6-induced cardiac myocyte dysfunction
por: Jin, Huiling, et al.
Publicado: (2019)

Effects of Clenbuterol, a β(2)-Adrenergic Agonist, on Sizes of Masseter, Temporalis, Digastric, and Tongue muscles
por: Ishikawa, Chieko, et al.
Publicado: (2009)

Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice
por: Ito, Aiko, et al.
Publicado: (2023)

Oral angiotensin-converting enzyme inhibitor captopril protects the heart from Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice
por: Kiyomoto, Kenichi, et al.
Publicado: (2023)

Role of TLR4 signaling on Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice
por: Matsuo, Ichiro, et al.
Publicado: (2022)

Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy
por: Jiang, Guang-Liang, et al.
Publicado: (2011)

Insulin signaling pathway in the masseter muscle of dexamethasone-treated rats
por: de França, Igor Rabelo, et al.
Publicado: (2018)

Changes in the Expression of Myosins During Postnatal Development of Masseter Muscle in the Microphthalmic Mouse
por: Katayama, R., et al.
Publicado: (2010)

Clenbuterol: Acute myocarditis: case report
Publicado: (2022)

Kinetic Analysis of the Slow Skeletal Myosin MHC-1 Isoform from Bovine Masseter Muscle
por: Bloemink, M.J., et al.
Publicado: (2007)

Development of Polyclonal Antibody against Clenbuterol for Immunoassay Application
por: Talib, Nurul Ain A., et al.
Publicado: (2018)

Effects of clenbuterol administration on mitochondrial morphology and its regulatory proteins in rat skeletal muscle
por: Kitaoka, Yu, et al.
Publicado: (2019)

Changes in skeletal muscle gene expression following clenbuterol administration
por: Spurlock, Diane M, et al.
Publicado: (2006)

Protection of spinal cord ischemic injury with the β-agonist Clenbuterol
por: DaSilva, MC, et al.
Publicado: (2000)

Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth
por: Brown, David M., et al.
Publicado: (2018)

Unsuspected Clenbuterol Toxicity in a Patient Using Intramuscular Testosterone
por: Griswold, Matthew K., et al.
Publicado: (2017)

Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol
por: Cameron, Robert B., et al.
Publicado: (2017)

Spasm of the Masseters, with Complications
por: Nighbert, J. D.
Publicado: (1900)

Quercetin glycosides prevent dexamethasone-induced muscle atrophy in mice
por: Otsuka, Yuta, et al.
Publicado: (2019)

Calculate of withdrawal times of clenbuterol in goats to obtain safe times of slaughter
por: Mochamad, Lazuardi, et al.
Publicado: (2018)

Rapid Detection of Clenbuterol Residues in Pork Using Enhanced Raman Spectroscopy
por: Guo, Qinghui, et al.
Publicado: (2022)

Idiopathic Masseter Muscle Hypertrophy
por: Kebede, Biruktawit, et al.
Publicado: (2011)

Myositis Ossificans of the Masseter Muscle
por: Kayal, L., et al.
Publicado: (2018)

Benign masseter muscle hypertrophy
por: Rispoli, Daniel Zeni, et al.
Publicado: (2015)

Dystrophic calcification in the masseter muscle
por: Walulik, Agata, et al.
Publicado: (2023)

Differential gene expression profile in pig adipose tissue treated with/without clenbuterol
por: Zhang, Jin, et al.
Publicado: (2007)

Impact of Combined Clenbuterol and Metoprolol Therapy on Reverse Remodelling during Mechanical Unloading
por: Navaratnarajah, Manoraj, et al.
Publicado: (2014)

Adverse Effects from Clenbuterol and Ractopamine on Nematode Caenorhabditis elegans and the Underlying Mechanism
por: Zhuang, Ziheng, et al.
Publicado: (2014)

Differential expression of skeletal muscle genes following administration of clenbuterol to exercised horses
por: Knych, Heather K., et al.
Publicado: (2016)

Author Correction: Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol
por: Cameron, Robert B., et al.
Publicado: (2019)

Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells
por: Meister, Jaroslawna, et al.
Publicado: (2022)

Controlled release of Clenbuterol from a hydroxyapatite carrier for the treatment of Alzheimer’s Disease
por: Lin, Yi-Wen, et al.
Publicado: (2023)

Myosin Heavy-Chain Messenger Ribonucleic Acid (mRNA) Expression and Fibre Cross-Sectional Area in Masseter, Digastric, Gastrocnemius and Soleus Muscles of Young and Adult Rats
por: Lagou, Aikaterini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_74bhhr200ahjns8ihi2aetbsi2